Skip to main content
Innovative Medical Management Co.,Ltd. logo

Innovative Medical Management Co.,Ltd. — Investor Relations & Filings

Ticker · 002173 ISIN · CNE1000007J6 Shenzhen Stock Exchange Human health and social work activities
Filings indexed 2,161 across all filing types
Latest filing 2026-05-11 Director's Dealing
Country CN China
Listing Shenzhen Stock Exchange 002173

About Innovative Medical Management Co.,Ltd.

https://www.chxyl.com

Innovative Medical Management Co., Ltd. specializes in hospital management and the provision of comprehensive medical services. The company operates through a network of healthcare institutions, focusing on clinical diagnosis, treatment, and specialized medical care. Its core business model involves the acquisition, investment, and integrated management of private hospitals to improve operational efficiency and service quality. Key facilities under its management include Jianhua Hospital, Kanghua Hospital, and Fuhua Hospital. The company leverages modern management techniques and medical technology to deliver healthcare solutions across various clinical departments, including oncology, cardiovascular care, and rehabilitation. By integrating medical resources and optimizing hospital workflows, the company aims to provide high-quality patient care and expand its footprint in the healthcare services sector.

Recent filings

Filing Released Lang Actions
关于董事减持计划期间届满暨实施结果的公告
Director's Dealing Classification · 95% confidence The document is an announcement of a director’s personal share reduction plan and the actual implementation results, including detailed insider trading data (dates, share counts, prices) by director Ruan Guangyin. This clearly matches the definition for Director's Dealing (insider transactions by company directors).
2026-05-11 Chinese
关于召开2025年度网上业绩说明会的通知
Investor Presentation Classification · 95% confidence The document is a notice about the scheduling of an online earnings explanation meeting (业绩说明会) for the 2025 fiscal year. It references that the 2025 Annual Report has already been disclosed on April 25, 2026, and invites investors to participate in a webcast on May 19, 2026. The document does not contain actual financial data or detailed financial statements but is an announcement about an upcoming investor presentation event. The length is short (635 characters), and it serves as a notification rather than the report itself. Therefore, it fits best under Investor Presentation (IP) as it is a detailed presentation event for investors focusing on financials and company performance.
2026-05-07 Chinese
股票交易异常波动公告
Regulatory Filings Classification · 95% confidence The document is a public announcement regarding abnormal stock price fluctuations of the company '创新医疗管理股份有限公司' (Innovative Medical Management Co., Ltd.) with stock code 002173. It explains the situation of stock price volatility over specific trading days, the company's investigation and confirmation that no undisclosed material information exists, and a risk warning to investors. The document is short (1331 characters) and focuses on stock trading behavior and regulatory compliance disclosures rather than financial results or detailed reports. It does not contain financial statements, management discussion, or audit information. This type of announcement fits the category of a Regulatory Filing (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other specific categories.
2026-01-12 Chinese
股票交易异常波动公告
Regulatory Filings Classification · 95% confidence The document is a public announcement regarding abnormal stock price fluctuations for the company 创新医疗管理股份有限公司 (Innovative Medical Management Co., Ltd.). It explains the situation of stock price volatility over three trading days, confirms no undisclosed material information, and provides risk warnings to investors. The document is short (1160 characters) and serves as a regulatory disclosure about stock trading anomalies rather than a financial report or detailed analysis. It does not contain financial statements, management discussion, or audit information. It is a regulatory announcement related to stock trading compliance and information disclosure rules under Shenzhen Stock Exchange regulations. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2026-01-07 Chinese
关于签署参股公司全诊医学《B+轮增资协议》《B+轮股东协议》及相关文件的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the signing of investment agreements related to a B+ round financing in a subsidiary company, Hangzhou Quanzhen Medical Technology Co., Ltd. It details the investment parties, shareholding changes, and board approvals. There is no financial statement, earnings data, or management discussion of financial results. The document is a formal disclosure of a capital investment transaction and related agreements, which fits the category of Capital/Financing Update (CAP). The document length is about 5991 characters, sufficient for a detailed announcement but not a full financial report. Therefore, the classification is CAP with high confidence.
2025-12-12 Chinese
第七届董事会2025年第四次临时会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of a board meeting resolution by the company '创新医疗管理股份有限公司'. It details the convening of the 7th Board's 4th interim meeting in 2025, the voting results, and the approval of agreements related to a financing round of an associated company. There is no financial data, no full report, no audit, no earnings release, or other detailed financial or regulatory filings. The document is about board decisions and approvals, specifically about signing investment agreements and waiving preemptive rights. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board or senior management. The document length is short and focused on board resolutions, not a full report or announcement of a report publication. Therefore, the classification is MANG with high confidence.
2025-12-12 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.